ARCHIVES

DCT To Examine Groups’ Studies, Directions, Role in 2000 A.D. Goal

This article is from The Cancer Letter archive.

Vol. 10 No. 23 | June 8, 1984

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

“If We Had More Resources, It’s A Fantastic Time” For Cancer Research

May 12, 1995

Review Planned Of 54 Deaths In First 60 Days On Studies.

June 22, 2001

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

NCI’s Kramer Named Director, NIH Medical Applications Office.

June 16, 2000